Two respected radiology organizations have issued a stark warning on the new recommendations, stating that they risk confusing patients and “may contribute to thousands of additional breast cancer deaths each year.”
"This case reflects a troubling pattern in which payers, dissatisfied with IDR results, increasingly try to attack those outcomes outside the framework Congress created," Rad Partners says.
“Expanding residency slots and mitigating workforce attrition will be necessary to mitigate increasing workforce gaps," experts write in the Journal of the American College of Radiology.
Landiolol, sold under the brand name Rapiblyk, is only meant to be administered in a hospital setting. It was initially approved for adult patients in 2024.
Join us for a Radiology Business webinar and live Q&A on Tuesday, April 21, with leaders from this seven-center imaging group and a veteran financial expert.
Almost 15% of more than 5,500 U.S. adults—representing around 14 million individuals—have skipped a doctor visit after feeling satisfied enough with health advice they received from AI.
